| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.06.06 | Novartis Launches Global Program Expanding Access to Investigational Compound Nilotinib (AMN107) for Patients With Hard-to-Treat Leukemia | 45 | PR Newswire | EAST HANOVER, N.J., June 4 /PRNewswire/ -- Novartis announced today the launch of a global program, ENACT (Expanding Nilotinib Access in Clinical Trials), to provide expanded access to nilotinib (AMN107)... ► Artikel lesen | |
| 04.06.06 | GSK licenses cancer antigen portfolio from Ludwig Institute for Cancer Research | 59 | AFX News | PHILADELPHIA (AFX) - GlaxoSmithKline and the New York-based Ludwig Institute for Cancer Research said GSK has licensed a substantial portfolio of tumor-specific antigens from LICR.
Financial... ► Artikel lesen | |
| 04.06.06 | GSK cancer immunotherapy MAGE-A3 reduces risk of cancer recurrence - study | 38 | AFX News | PHILADELPHIA (AFX) - GlaxoSmithKline said interim results from a Phase 2 clinical trial in patients
treated with GSK's investigational MAGE-A3 antigen specific cancer
immunotherapeutic (ASCI)... ► Artikel lesen | |
| 04.06.06 | Montenegro spends its first day as independent country | 28 | AFX News | PODGORICA (AFX) - Montenegro spent its first day as a sovereign state Sunday following a proclamation of independence that finally disbanded the last remnant of the former Yugoslav federation.
... ► Artikel lesen | |
| 04.06.06 | GSK lung cancer jab fails to show significant reduction in disease recurrence | 51 | AFX News | LONDON (AFX) - Initial results from a trial of GlaxoSmithKline PLC's early-stage cancer vaccine MAGE-A3 failed to demonstrate a statistically significant reduction in risk of cancer recurrence... ► Artikel lesen | |
| 04.06.06 | Harrah's faces possible shutout in Asia | 89 | AFX News | LAS VEGAS (AFX) - Five years ago, the casino company that is now Harrah's Entertainment Inc. decided not to bid for a gambling license in the booming Chinese enclave of Macau while its competitors... ► Artikel lesen | |
| 04.06.06 | Swatch's Hayek sees group sales rising by 1.5 times by 2009 | 41 | AFX News | ZURICH (AFX) - Swatch Group AG chairman Nicolas Hayek expects group sales to increase by 1.5 times within three years, equalling sales of around 7 bln sfr, up from 4.497 bln sfr in 2005.
In... ► Artikel lesen | |
| 04.06.06 | Storage demands flash memory industry | 49 | AFX News | SAN JOSE, Calif. (AFX) - Bill Healy held the future in his pocket.
The senior vice president of Hitachi Global Storage Technologies Inc. whipped out a tiny hard drive about the size of... ► Artikel lesen | |
| 04.06.06 | Addition of VELCADE(R) (Bortezomib) for Injection Improved survival in Front-Line Advanced Lung Cancer | 31 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced the final results from a Phase II study conducted by the Southwest Oncology Group (SWOG) that showed a median... ► Artikel lesen | |
| 04.06.06 | Cambior to temporarily close Guyana mine | 39 | AFX News | GEORGETOWN, Guyana (AFX) - Cambior Inc. will shut down its bauxite mine in Guyana for July and August due to stiff competition from Chinese firms, officials said.
The Montreal-based company... ► Artikel lesen | |
| 04.06.06 | Oil jitters may spell trouble for Wall St. | 37 | AFX News | NEW YORK (AFX) - With the latest batch of economic numbers doing little to dispel investors' uncertainty about the economy, turbulence in the energy market could make Wall Street's ride bumpier... ► Artikel lesen | |
| 04.06.06 | UBS to step up acquisitions while accelerating organic growth | 37 | AFX News | ZURICH (AFX) - UBS AG will step up its acquisition activities while also accelerating its organic growth, deputy group chief executive Marcel Rohner told Sonntagszeitung newspaper.
Increased... ► Artikel lesen | |
| 04.06.06 | Results of Phase II Studies Measure Progression Free Survival for ZACTIMA (ZD6474) in Lung Cancer | 33 | PR Newswire | ATLANTA, June 4 /PRNewswire-FirstCall/ -- AstraZeneca announced today the results of two Phase II studies, Trial 003 and 006, with ZACTIMA (ZD6474), a compound which targets both epidermal growth... ► Artikel lesen | |
| 04.06.06 | Vonage sued over initial public offering | 37 | AFX News | HOLMDEL, N.J. (AFX) - Vonage Holdings Corp. is the target of a class action lawsuit that claims the Internet phone company improperly steered consumers toward investing in its $531 million initial... ► Artikel lesen | |
| 04.06.06 | GlaxoSmithKline reports low incidence of heart problems in Tykerb trials | 34 | AFX News | LONDON (AFX) - GlaxoSmithKline PLC reported a 'low incidence' of heart problems in women taking part in all trials of its experimental breast cancer drug Tykerb to date.
Setting out the results... ► Artikel lesen | |
| 04.06.06 | New contact lenses give athletes an edge | 364 | AFX News | BRENTWOOD, Tenn. (AFX) - When Camille Walters plays soccer, her normally brown eyes have a spooky red tint. That's because the 15-year-old wears tinted contact lenses that block certain wavelengths... ► Artikel lesen | |
| 04.06.06 | Amgen says study shows denosumab suppressed bone turnover in cancer patients | 27 | AFX News | LONDON (AFX) - Amgen Inc said interim data from two Phase 2 clinical studies showed that treatment with denosumab resulted in a rapid suppression of bone turnover among advanced cancer patients... ► Artikel lesen | |
| 04.06.06 | GSK Licenses Cancer Antigen Portfolio From Ludwig Institute for Cancer Research | 59 | PR Newswire | PHILADELPHIA, NEW YORK, and LONDON, June 4 /PRNewswire-FirstCall/ -- GlaxoSmithKline and the international Ludwig Institute for Cancer Research (LICR) today announce they have entered into an agreement... ► Artikel lesen | |
| 04.06.06 | Encouraging Results of a Clinical Study With GSK's Novel Cancer Immunotherapy Report Activity in Patients With Most Common Form of Lung Cancer | 41 | PR Newswire | PHILADELPHIA, June 4 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced that interim results from a clinical trial in patients treated with GSK's investigational MAGE-A3 Antigen Specific Cancer... ► Artikel lesen | |
| 04.06.06 | 'Break-Up' earns $38.1M to top box office | 31 | AFX News | LOS ANGELES (AFX) - Supported by real-life romantic splits and hookups, Jennifer Aniston and Vince Vaughn's 'The Break-Up' pulled an upset over the mutant world of the 'X-Men.'
'The Break-Up'... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 3.627 |
| RHEINMETALL | 3.296 |
| VARTA | 3.142 |
| NVIDIA | 3.083 |
| NEL | 2.836 |
| TESLA | 2.409 |
| RENK GROUP | 2.181 |
| DEUTSCHE LUFTHANSA | 2.076 |
| BAYER | 2.053 |
| SUPER MICRO COMPUTER | 1.990 |
| AIXTRON SE | 1.670 |
| BYD | 1.564 |
| BASF | 1.217 |
| DEUTSCHE BANK | 1.214 |
| NETFLIX | 1.095 |
| EVOTEC | 1.071 |
| RWE | 1.051 |
| COMMERZBANK | 974 |
| SARTORIUS AG VZ | 958 |
| PLUG POWER | 905 |
| BARRICK GOLD | 900 |
| ALLIANZ | 884 |
| INFINEON | 875 |
| THYSSENKRUPP | 875 |
| MERCEDES-BENZ | 872 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
